Want to see RARE full AI Analyst Report?
Ultragenyx Pharmaceutical (RARE) Revenue
Ultragenyx Pharmaceutical Revenue
Ultragenyx Pharmaceutical had a revenue of 214.00M in the quarter ending Jun 30, 2026, with 57.35%. This bring the company's revenue in the last twelve months to 716.93M, Increased 7.10%. In the fiscal year ending Dec 31, 2025, Ultragenyx Pharmaceutical had annual revenue of 673.00M with 20.13% growth.
- Revenue (ttm)
- 716.93M
- Revenue Growth
- 17.50%
- P/S Ratio
- 2.36
- Revenue/Employee
- $490,883
- Employees
- 1,371
- Market Cap
- $1.59B
Revenue Chart
Ultragenyx Pharmaceutical Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 673.00M | 112.77M | 20.13% |
| Dec 31, 2024 | 560.23M | 125.98M | 29.01% |
| Dec 31, 2023 | 434.25M | 70.92M | 19.52% |
| Dec 31, 2022 | 363.33M | 11.92M | 3.39% |
| Dec 31, 2021 | 351.41M | 80.38M | 29.66% |
| Dec 31, 2020 | 271.03M | 167.32M | 161.32% |
| Dec 31, 2019 | 103.71M | 52.22M | 101.41% |
| Dec 31, 2018 | 51.49M | 48.88M | 1871.48% |
| Dec 31, 2017 | 2.61M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.